.
system structurally, evolutionarily and functionally.
So far, several groups have reported the biological In the G-protein-coupled receptor superfamily, the functions of the nociceptin system. In contrast to the opioid receptor subfamily is constituted of the three opioid peptides with analgesic effects, nociceptin induced distinct opioid receptors (namely δ-, μ-and κ-subtypes) hyperalgesia or allodynia, when administered intraand the receptor for nociceptin (also designated cerebroventricularly (i.c.v.) or intrathecally, respectively orphaninFQ). The members of the opioid receptor (Meunier et al., 1995; Okuda-Ashitaka et al., 1996) . subfamily were known to mediate a variety of cellular Nociceptin caused a decrease in locomotor activity (Reininhibitory effects. The three opioid receptors are known scheid et al., 1995) . Inhibition of expression of the to play central roles in mediating analgesia and many nociceptin receptor reduced immunoglobulin production, other physiological activities; however, the nociceptin and a mitogen induced expression of nociceptin receptor receptor was identified recently and less is known mRNA in lymphocytes (Halford et al., 1995; Wick et al. , about its physiological roles. Here we report the genera-1995). Expression of nociceptin precursor mRNA was tion and characterization of mice lacking the nociceptin regulated by intracellular cAMP levels in NS20Y neuroreceptor. The knockout mice showed no significant blastoma cells (Saito et al., 1996) . The reported results differences in nociceptive threshold and locomotor suggested important roles for the nociceptin system in activity compared with control mice, but they lost modulation of the nociceptive threshold, locomotor nociceptin-induced behavioral responses. These results activity, immunological responses and neuronal developindicate that the nociceptin system is not essential for ment. However, specific antagonists for the nociceptin regulation of nociception or locomotor activity. On the receptor are not available, and the physiological roles of other hand, we found insufficient recovery of hearingIntroduction in the mutants. The results clearly demonstrated an essenMultiple binding sites for opioid ligands have been identitial role for the nociceptin system in regulation of the fied based on pharmacological studies, and the opioid auditory system. receptors have been shown to mediate a variety of cellular inhibitory effects, including inhibition of adenylate
Results and discussion
cyclase, activation of potassium channels and inhibition of calcium channels (Loh and Smith, 1990) . Previous Generation of mutant mice lacking the nociceptin DNA cloning studies have shown that in the G-proteinreceptor linked receptor superfamily (Hille, 1992 ) the opioid As shown in Figure 1A , genomic DNA fragments from the mouse nociceptin receptor gene receptor subfamily is constituted of three opioid receptors In the targeting vector, restriction enzyme sites used for construction and linearization are also shown; enzyme sites in parentheses are deleted by the construction. For detection of the targeted mutation, a synthetic linker was introduced between the 5Ј genomic and lacZ fragments in the vector. (B) Southern blot of tail DNAs from littermates obtained by crossing between the heterozygous mutants. BamHI-digested DNA was analyzed using the probe 1 shown in (A). The 2.7 and 7.1 kb fragments are expected from the wild-type and mutant allele, respectively, and the 1.6 kb fragment is expected from both alleles. The size markers are indicated in kbp.
were used to construct a targeting vector, in which the first protein-coding sequence (P1) is replaced with a lacZneo cassette and the sequence of the lacZ gene encoding bacterial β-galactosidase is linked to the 5Ј-non-coding sequence. In the expected mutant allele, it is thus possible to express the lacZ gene under the control of the transcription machinery of the nociceptin receptor gene. The gene targeting and generation of mutant mice were performed essentially as described previously ; in the experimental procedures, we used J1 embryonic stem (ES) cells derived from a 129 strain mouse and C57BL/6J mice to cross with chimeric males. Two lines of mice carrying the mutant allele designated as morc m1 were established using independent ES clones positive in Southern blot analysis ( Figure 1B) .
RNA blot hybridization analysis failed to detect mRNA for the nociceptin receptor in the brains of the homozygous mice ( Figure 2A) ; therefore, the morc m1 mutation seems to be a null mutation in the gene. On the other hand, the expression levels of nociceptin precursor mRNA are comparable in the brains of mutant and control mice ( Figure 2B ). The homozygous mice obtained were healthy and fertile, and we could not find any anatomical abnorm- Figure 1A ) for nociceptin receptor mRNA in (A), the cDNA probe experiments described below. for nociceptin precursor mRNA in (B) and the cDNA probe (Clontech Laboratories, Inc.) for β-actin mRNA in (C). The data were derived from a blotting sheet re-used successively. The Nociception in mice lacking the nociceptin size markers are indicated in kb.
receptor Because hyperalgesia and allodynia induced by nociceptin have been reported (Meunier et al., 1995; Okuda-Ashitaka nociceptive system, the loss of the nociceptin receptor might result in anti-nociceptive effects in the mutant mice. et al., 1996) , we conducted the heat tail-flick test to compare nociceptive thresholds in the nociceptin receptor-
In accordance with the reported data, nociceptin induced hyperalgesia when administered i.c.v. to wild-type mice. deficient and control mice ( Figure 3A and B). If the nociceptin system functioned as a major regulator in the In contrast, we could not find a significant difference in
The results clearly show that nociceptin-induced hyperalgesia is mediated by the product derived from the nociceptin receptor gene, and also indicate that regulation by the nociceptin system is not essential for the determination of the nociceptive threshold in vivo. However, our data cannot eliminate the possibility that neuromodulation systems other than the nociceptin system, for example opioid peptide systems, may compensate for abnormalities in the mutant mice. On the other hand, the loss of the nociceptin system does not affect the morphine-induced anti-nociceptive response ( Figure 3B ). Recently, it was reported that mutant mice lacking the μ-opioid receptor lost morphine-induced anti-nociceptive effects but showed an apparently normal nociceptive threshold (Matthes et al., 1996) . Together these observations may suggest that the nociceptive threshold is regulated by highly compensating mechanisms in the central nervous system.
Locomotion in mice lacking the nociceptin receptor
The spontaneous locomotor activity of the mutant mice was then examined because reduction of locomotor activity by nociceptin administration was observed (Reinscheid et al., 1995) . Assuming that the nociceptin system was a dominant modulation system in locomotor activity, hyperactivities might be expected in the mutant mice. However, the results showed a slightly reduced locomotor activity of the homozygous mutants as compared with that of control mice (Figure 4) . We also examined the effects of nociceptin administration on locomotor activity. Nociceptin-induced hypoactivity was observed in wildtype mice as reported previously, but we could not detect any obvious effect of nociceptin in the homozygous mutants (Figure 4 ). These results show that disruption of the nociceptin receptor gene results in the loss of nociceptin-induced hypolocomotion.
The results of nociceptin-induced hypolocomotion in wild-type mice and the tendency to hypolocomotion in the homozygous mutants seem to be mutually exclusive. knockout mice with the mixed 129-C57BL genotype exhibit hypoactivity (Gerlai, 1996) . Nevertheless, the absence of any obvious abnormality in locomotor activity the latency of the tail-flick response to heat between the untreated homozygous mutants and those treated with of the mutant mice suggests that the nociceptin system is not a major determinant in the regulation of locomotion nociceptin. However, no measurable difference in nociceptive thresholds was observed between the untreated in the central nervous system. mutant and control mice under different conditions of heat intensity ( Figure 3A and B) . Moreover, we also examined
The immune system in mice lacking the nociceptin receptor nociceptive thresholds in the test using acetic acid-induced writhing behavior, a test that allows a more sensitive It was reported that antisense oligonucleotides for the nociceptin receptor inhibit immunoglobulin production in detection of the thresholds than the tail-flick test ( Figure  3C ). Again the mutant mice showed nociceptive thresholds B-lymphocytes and that mitogen stimulation resulted in a remarkable induction of the level of nociceptin receptor comparable with that of control mice. system is not essential for lymphocyte proliferation and immunoglobulin production.
Regional distribution of the nociceptin receptor and nociceptin precursor
As expected from the targeting construct, neurons expressing the nociceptin receptor can be detected by β-galactosidase activity in the mutant mice. Indeed, the regions positive in X-gal staining in brain and spinal cord from mutants ( Figure 5A -G) almost correspond with the areas positive in previous in situ experiments with antisense probes for the nociceptin receptor mRNA (Fukuda et al., 1994; Mollereau et al., 1994) . Furthermore, the brain and spinal cord areas with predominant expression of the nociceptin precursor message ( Figure 5H -K) appeared identical to the sites that exhibit significant levels of β-galactosidase activity ( Figure 5E-G) . These results, together with our previous observations , indicate that the nociceptin receptor in these sites may be located on, or afforded many synapses by, nociceptin neurons. They also imply that the nociceptin system may modulate a variety of neurons in central nervous system sites, including the sensory and auditory pathways and centers implicated in emotion and autonomic control.
Hearing ability in mice lacking the nociceptin receptor
With the evidence for nociceptin and its receptor in brainstem auditory stations as shown above, we then examined the hearing ability of the mutant mice. Morphologically, the middle and inner ears and acoustic nerve of the mutant mice appeared normal (data not shown). The auditory brainstem responses (ABRs) measured in untreated mutant mice showed normal waveforms and thresholds (average threshold value: 37 dB SPL), which are comparable with those obtained in control mice (Colvin et al., 1996) . However, following exposure to intense sound, the thresholds of ABRs in the homozygous mutants showed a significant rise ( Figure 6A ). The threshold shift was considered temporary because the ABRs recovered completely to normal levels within 3 days ( Figure 6B ). ( Vetter et al., 1991; Brown, 1993; Simmons et al., 1996) . Unlike other sensory systems, these efferent neurons present outstanding features for the auditory system mRNA in peripheral blood lymphocytes (Halfold et al., 1995; Wick et al., 1995) . These observations may suggest because they have pivotal roles in directly influencing both the central auditory nuclei and the periphery important immunological roles for the nociceptin system. However, we detected no abnormalities in the immuno- (Brown, 1993) . Stimulation or surgical impairment of the olivocochlear bundle has been shown to produce changes globulin content of peripheral blood from nociceptin receptor-deficient mice (data not shown). Moreover, in in cochlear mechanics, afferent fiber activities and efficiencies of signal detection (Dewson, 1968; Borg, 1971 ; flow cytometric analysis using antibodies to specific cell surface markers, we identified no abnormal populations Klinke and Galley, 1974; Mountain, 1980; Cody and Johnstone, 1982) . The nociceptin system may modulate of T-and B-lymphocytes in the blood and bone marrow (data not shown). These results suggest that the nociceptin the excitability of the olivocochlear bundle and/or cochlear DNA and RNA preparations from tissues of adult mice were performed as described previously .
Behavioral analyses
Male mice were used for behavioral analyses. Analgesia was determined using the radiant heat, tail-flick technique (D'Amour and Smith, 1941) . The latency to withdraw the tail from a focused light stimulus was measured electronically, using a photocell. For analyzing the effects of nociceptin, the latencies were measured 10 min after administration of nociceptin (1 or 10 nmol, i.c.v.) and were compared with baseline latencies. To examine the effects of morphine (10 mg/kg, s.c.) the latencies in mice were determined 60 min after administration. We used a higher intensity of light stimulation to examine the morphine-induced anti-nociceptive effects and a lower intensity to analyze the nociceptininduced hyperalgesic effects. The maximum latency to response of 15 and 20 s would not induce tissue damage in mice treated with morphine and nociceptin, respectively. Mice tested in the writhing assay received an injection (10 ml/kg, i.p.) of 0.7% acetic acid. The number of writhes, characterized by a wave of contraction of the abdominal muscles followed by extension of the hind limbs, was counted for 10 min, beginning 5 min after the injection.
To determine locomotor activity (Noda et al., 1995) , each animal was placed individually in a transparent acrylic cage (26ϫ44ϫ40 cm) and the locomotor count was recorded over 30 min using digital counters with infrared cell sensors placed on the walls (SCANET SV-10, Toyosangyo Co., Japan). To examine the effects of nociceptin, mice were injected with nociceptin (1 or 10 nmol, i.c.v.) and 10 min later the locomotor activities of the mice were measured. Experiments were carried out from 11:00 to 15:00.
Anatomical analyses
For β-galactosidase staining, mice were perfused with a 2% paraformaldehyde solution buffered with 0.12 M sodium phosphate (pH 7.4) under Fig. 6 . Sound-induced threshold shifts of auditory brainstem responses pentobarbital anesthesia, and the brains and spinal cords were immersed (ABRs) in nociceptin receptor-deficient mice. (A) Thresholds of ABRs immediately in ice-cold 25% sucrose. Frozen coronal sections (40 μm measured before and 60 min after sound exposure (110 dB). After thickness) were stained with the X-Gal reagent (Bajocchi et al., 1993) . sound exposure, the homozygous mutants displayed a significant rise For in situ hybridization, mice were perfused with a fixative containing in ABR thresholds. In contrast, all the other mice showed no distinct 4% paraformaldehyde, 2% glutaraldehyde and 0.12 M sodium phosphate changes. Thresholds of ABRs were the lowest intensities (dB SPL) of (pH 7.4). Brains and spinal cords were cut into coronal sections (50 μm click sound below which significant ABR waves disappeared, and are thickness) and analyzed with the probe for nociceptin precursor mRNA presented as means Ϯ SEM (n ϭ 7 in each group). The data were as described previously . analyzed by ANOVA followed by a post-hoc Fisher's PLSD; the comparisons of threshold values between pre-and post-sound exposure Auditory brainstem responses are significant only in the homozygous mutants (*P Ͻ0.01).
ABRs were measured (Colvin et al., 1996) before and after sound (B) Temporal profiles of ABRs at 50 dB SPL from a wild-type mouse exposure using chloral hydrate-administered mice by means of stepwise and a nociceptin receptor-deficient mutant. Both mice showed normal 0.1 ms click sound stimulations. Intense sound (1 kHz continuous pure ABR patterns at pre-sound exposure and 3 days after sound exposure; tone at 110 dB SPL for 60 min) was applied to the mice in a however, the waveforms diminished to no response at 60 and 90 min soundproof room. only in the mutant mouse.
hair cells for the regulation of the auditory system. The
